Genzyme Tissue Repair (GZTR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Knighty Tin who wrote (2518)	3/6/2000 10:12:00 AM
From: Greg Jung	Read Replies (1) of 2553

Merger Alert: GZTR is involved in the 3-way to be held with Biomatrix (BXM). Genzyme Biosurgery. BXM holders get guaranteed $37/share cash or 1 share in new company, GZTR get .335 share GZSP gets .606 share. Based on $37 value GZTR and GZSP closed at 26% discounts. GZTR opened up+1, dropped to hit my bid at 9 1/2 :) about 10 am and seems to have bounced back up. BXM makes actual earnings and has increasing revenues from new products.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next